Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia

F Mouaffak, C Tranulis, R Gourevitch… - Clinical …, 2006 - journals.lww.com
Background: Approximately 40% to 70% of neuroleptic-resistant schizophrenic patients are
nonresponders to clozapine. Several clozapine augmentation strategies have come into …

Augmentation Strategies of Clozapine With Antipsychotics in the Treatment of Ultraresistant Schizophrenia

F Mouaffak, C Tranulis, R Gourevitch… - Clinical …, 2006 - journals.lww.com
Background: Approximately 40% to 70% of neuroleptic-resistant schizophrenic patients are
nonresponders to clozapine. Several clozapine augmentation strategies have come into …

Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.

F Mouaffak, C Tranulis, R Gourevitch… - Clinical …, 2006 - europepmc.org
Background Approximately 40% to 70% of neuroleptic-resistant schizophrenic patients are
nonresponders to clozapine. Several clozapine augmentation strategies have come into …

Augmentation strategies of clozapine with antipsychotics in the treatment of ultra resistant schizophrenia.

F Mouaffak, C Tranulis, R Gourevitch… - Clinical …, 2006 - psycnet.apa.org
Background: Approximately 40% to 70% of neuroleptic-resistant schizophrenic patients are
nonresponders to clozapine. Several clozapine augmentation strategies have come into …

Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia

F Mouaffak, C Tranulis, R Gourevitch… - Clinical …, 2006 - pubmed.ncbi.nlm.nih.gov
Background Approximately 40% to 70% of neuroleptic-resistant schizophrenic patients are
nonresponders to clozapine. Several clozapine augmentation strategies have come into …

[引用][C] Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia

F MOUAFFAK, C TRANULIS… - Clinical …, 2006 - Lippincott Williams & Wilkins